These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 33407447)

  • 21. Challenges in policy reforms for non-communicable diseases: the case of diabetes in Kenya.
    Shiroya V; Neuhann F; Müller O; Deckert A
    Glob Health Action; 2019; 12(1):1611243. PubMed ID: 31117896
    [No Abstract]   [Full Text] [Related]  

  • 22. The contribution of Cyprus to non-communicable diseases and biomedical research from 2002 to 2013: implications for evidence-based health policy.
    Pallari E; Lewison G; Pallari CT; Samoutis G; Begum M; Sullivan R
    Health Res Policy Syst; 2018 Aug; 16(1):82. PubMed ID: 30119676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Public health concern and initiatives on the priority action towards non-communicable diseases in Tanzania.
    Mfinangai SG; Kivuyo SL; Ezekiel L; Ngadaya E; Mghamba J; Ramaiya K
    Tanzan J Health Res; 2011 Dec; 13(5 Suppl 1):365-77. PubMed ID: 26591991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strengthening non-communicable disease policy with lessons from Bhutan: linking gross national happiness and health policy action.
    Sithey G; Li M; Thow AM
    J Public Health Policy; 2018 Aug; 39(3):327-342. PubMed ID: 29950574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Big food and the World Health Organization: a qualitative study of industry attempts to influence global-level non-communicable disease policy.
    Lauber K; Rutter H; Gilmore AB
    BMJ Glob Health; 2021 Jun; 6(6):. PubMed ID: 34117011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Scoping Review of Policies Related to the Prevention and Control of Overweight and Obesity in Africa.
    Adom T; De Villiers A; Puoane T; Kengne AP
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of law and governance reform in the global response to non-communicable diseases.
    Magnusson RS; Patterson D
    Global Health; 2014 Jun; 10():44. PubMed ID: 24903332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systems Thinking and Complexity Science Methods and the Policy Process in Non-communicable Disease Prevention: A Systematic Scoping Review.
    Astbury CC; Lee KM; McGill E; Clarke J; Egan M; Halloran A; Malykh R; Rippin H; Wickramasinghe K; Penney TL
    Int J Health Policy Manag; 2023; 12():6772. PubMed ID: 37579437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and control of non-communicable diseases in antenatal, intrapartum, and postnatal care: a systematic scoping review of clinical practice guidelines since 2011.
    Jung J; Karwal EK; McDonald S; Turner T; Chou D; Vogel JP
    BMC Med; 2022 Sep; 20(1):305. PubMed ID: 36123668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The changing trend of capacity on policy implementation related to the prevention and control of chronic non-communicable disease at the provincial level, from 2011 to 2017].
    Si X; Zhai Y; Zhu XL; Ma JX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):726-730. PubMed ID: 31238627
    [No Abstract]   [Full Text] [Related]  

  • 31. The
    Lloyd-Williams F; Masters R; Hyseni L; Denny ES; O'Flaherty M; Capewell S
    Int J Health Policy Manag; 2021 Oct; 10(10):638-646. PubMed ID: 32610821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to tackle non-communicable diseases in Afghanistan: A scoping review.
    Neyazi N; Mosadeghrad AM; Afshari M; Isfahani P; Safi N
    Front Public Health; 2023; 11():982416. PubMed ID: 36908476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addressing non-communicable diseases in disaster risk reduction - an issue of equity.
    Gnanapragasam S; Aitsi-Selmi A; Rashbrook E; Murray V
    J Epidemiol Glob Health; 2016 Jun; 6(2):119-21. PubMed ID: 27001076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Framing and the health policy process: a scoping review.
    Koon AD; Hawkins B; Mayhew SH
    Health Policy Plan; 2016 Jul; 31(6):801-16. PubMed ID: 26873903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noncommunicable Disease Prevention and Control in Mongolia: A Policy Analysis.
    Chimeddamba O; Peeters A; Walls HL; Joyce C
    BMC Public Health; 2015 Jul; 15():660. PubMed ID: 26169789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlling and preventing climate-sensitive noncommunicable diseases in urban sub-Saharan Africa.
    Rother HA
    Sci Total Environ; 2020 Jun; 722():137772. PubMed ID: 32199361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systems Thinking as a Framework for Analyzing Commercial Determinants of Health.
    Knai C; Petticrew M; Mays N; Capewell S; Cassidy R; Cummins S; Eastmure E; Fafard P; Hawkins B; Jensen JD; Katikireddi SV; Mwatsama M; Orford J; Weishaar H
    Milbank Q; 2018 Sep; 96(3):472-498. PubMed ID: 30277610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of social impact bonds in financing health systems responses to non-communicable diseases: scoping review.
    Hulse ESG; Atun R; McPake B; Lee JT
    BMJ Glob Health; 2021 Mar; 6(3):. PubMed ID: 33674267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Health Promotion Policies for All in Taiwan].
    Wang YW
    Hu Li Za Zhi; 2018 Oct; 65(5):5-12. PubMed ID: 30276767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National Non-Communicable Diseases Conferences- A Platform to Inform Policies and Practices in Tanzania.
    Amani DE; Ndumwa HP; Ngowi JE; Njiro BJ; Munishi C; Mboya EA; Mloka D; Kikula AI; Balandya E; Ruggajo P; Kessy AT; Kitambala E; Kapologwe N; Kengia JT; Kiologwe J; Ubuguyu O; Salum B; Kamuhabwa A; Ramaiya K; Sunguya BF
    Ann Glob Health; 2024; 90(1):18. PubMed ID: 38463453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.